Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/27/2022* -- Results Q3 2022 -- 0.44 --
10/27/2022* 08:00 EST Earnings Call Q3 2022 -- -- --
07/27/2022 08:00 EST Earnings Call Q2 2022 -- -- --
07/27/2022 -- Results Q2 2022 0.44 0.42 3.96%
04/27/2022 -- Results Q1 2022 -- 0.39 --
04/27/2022 08:00 EST Earnings Call Q1 2022 -- -- --
02/02/2022 -- Results Q4 2021 0.45 0.44 2.51%
02/02/2022 08:00 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 10/27/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 07/27/2022
Beat/Miss Upgrade
Return Since -1.07%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
URL https://www.bostonscientific.com
Investor Relations URL https://investors.bostonscientific.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style Large Cap/Blend
Next Earnings Release Oct. 27, 2022 (est.)
Last Earnings Release Jul. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 6.22%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
39.17%
17.30%
14.61%
42.56%
27.96%
-20.50%
18.16%
-6.12%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-21.90%
--
--
--
--
--
136.2%
71.93%
56.43%
-17.91%
-0.34%
83.12%
14.96%
115.8%
49.32%
4.08%
-12.44%
137.2%
24.81%
66.32%
73.44%
-47.52%
90.05%
10.79%
-28.96%
--
--
--
--
--
--
-18.91%
-64.29%
As of October 03, 2022.

Profile

Edit
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
URL https://www.bostonscientific.com
Investor Relations URL https://investors.bostonscientific.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style Large Cap/Blend
Next Earnings Release Oct. 27, 2022 (est.)
Last Earnings Release Jul. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
FSMEX 648.59M USD 8.53%
HHL.TO 53.56M USD 4.92%
IHI 267.91M USD 4.53%
JDMRX 447.14M USD 2.63%
VGHCX 1.138B USD 2.51%
ECAT 38.04M USD 2.16%
JUEQX 399.71M USD 1.98%
EXG 45.82M USD 1.70%
VPMCX 992.04M USD 1.66%
MFELX 550.77M USD 1.55%
XLV 445.19M USD 1.20%
VHT 195.65M USD 1.05%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter BSX Tweets